Atomo Diagnostics Limited (AT1.AX)
AUD 0.02
(-5.0%)
AUD 0.02
(-5.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 4.08 Million AUD | 60.65% |
| 2023 | 2.54 Million AUD | -79.38% |
| 2022 | 12.33 Million AUD | 83.69% |
| 2021 | 6.71 Million AUD | 25.09% |
| 2020 | 5.36 Million AUD | 894.69% |
| 2019 | 539.73 Thousand AUD | 87.9% |
| 2018 | 287.25 Thousand AUD | -2.6% |
| 2017 | 294.93 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 2.16 Million AUD | 12.47% |
| 2024 FY | 4.08 Million AUD | 60.65% |
| 2024 Q2 | 1.92 Million AUD | 62.34% |
| 2023 Q4 | 1.18 Million AUD | -12.82% |
| 2023 Q2 | 1.35 Million AUD | -80.57% |
| 2023 FY | 2.54 Million AUD | -79.38% |
| 2022 Q2 | 5.34 Million AUD | 150.04% |
| 2022 FY | 12.33 Million AUD | 83.69% |
| 2022 Q4 | 6.99 Million AUD | 30.86% |
| 2021 Q2 | 4.57 Million AUD | 3.32% |
| 2021 FY | 6.71 Million AUD | 25.09% |
| 2021 Q4 | 2.13 Million AUD | -53.33% |
| 2020 FY | 5.36 Million AUD | 894.69% |
| 2020 Q4 | 4.43 Million AUD | 372.77% |
| 2020 Q2 | 937.32 Thousand AUD | 97.36% |
| 2019 FY | 539.73 Thousand AUD | 87.9% |
| 2019 Q4 | 474.92 Thousand AUD | 632.82% |
| 2019 Q2 | 64.8 Thousand AUD | 0.0% |
| 2018 FY | 287.25 Thousand AUD | -2.6% |
| 2017 FY | 294.93 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | -8.851% |
| Adherium Limited | 840.98 Thousand AUD | -385.924% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 93.55% |
| Anteris Technologies Ltd | 4.11 Million AUD | 0.597% |
| Control Bionics Limited | 5.12 Million AUD | 20.292% |
| CardieX Limited | 10.9 Million AUD | 62.528% |
| Compumedics Limited | 49.71 Million AUD | 91.781% |
| Cochlear Limited | 2.25 Billion AUD | 99.819% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 74.007% |
| Cyclopharm Limited | 27.13 Million AUD | 84.943% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 63.576% |
| Nova Eye Medical Limited | 23.32 Million AUD | 82.48% |
| HeraMED Limited | 402.89 Thousand AUD | -914.288% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -563.864% |
| ImpediMed Limited | 10.31 Million AUD | 60.398% |
| InhaleRx Limited | 1.2 Million AUD | -239.4% |
| LBT Innovations Limited | 1.25 Million AUD | -225.361% |
| Micro-X Limited | 15.22 Million AUD | 73.154% |
| Neurotech International Limited | 1963.00 AUD | -208078.044% |
| OncoSil Medical Limited | 1.56 Million AUD | -161.057% |
| PolyNovo Limited | 103.19 Million AUD | 96.04% |
| Respiri Limited | 456.91 Thousand AUD | -794.377% |
| SomnoMed Limited | 91.65 Million AUD | 95.541% |
| Universal Biosensors, Inc. | 6.63 Million AUD | 38.389% |
| Uscom Limited | 3.72 Million AUD | -9.651% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 52.866% |